Publication|Articles|November 17, 2026

Supplements

  • Practical Considerations for Stroke Prevention Across the Continuum

From Hospital to Home: Medication Reconciliation, Rehab Transitions, and Pharmacist-Led Patient Navigation

Fact checked by: Tracy Ann Politowicz
Listen
0:00 / 0:00

Key Takeaways

  • Multiple handoffs after ischemic stroke amplify discrepancy risk; functional dependence and cognitive impairment increase need for structured assessment of self-management capacity and home support.
  • Pharmacist reconciliation should verify complete preadmission use, resolve unintended discrepancies at each transition, and document rationales, recognizing variable evidence for downstream clinical benefit.
SHOW MORE

A clear and workable medication plan is an essential part of the transition home.

This content was independently produced by Pharmacy Times in partnership with Bayer HealthCare.

Consider JP, a hypothetical man, aged 76 years, who was admitted to the hospital with an acute ischemic stroke. Before admission, he was taking lisinopril for hypertension, metformin for type 2 diabetes, atorvastatin for hyperlipidemia, and tamsulosin for benign prostatic hyperplasia. During hospitalization, antithrombotic therapy is initiated, his statin is intensified, and his antihypertensive regimen is adjusted. Further medication changes occur during rehabilitation. By the time he returns home, his regimen looks different from the one he knew prior to admission. Who will help him understand and manage those changes?

Poststroke Medication Management: A High-Risk Transition

Stroke survivors such as JP often move through several care settings. Each handoff creates opportunities for medication omissions, duplication, and discrepancies when information is incomplete or when changes are not clearly communicated.1

Functional and cognitive limitations add to the challenge. In a Swedish cohort reported in 2006, 36% of survivors received help with personal activities of daily living at 1 year.2 In the 5-year ASPIRE-S follow-up, cognitive impairment was associated with greater use of help taking medications. The study did not establish that cognitive impairment caused poorer adherence.3 These findings support assessing what patients can manage and who will assist them at home.

Medication Reconciliation as a Core Pharmacist Function

Medication reconciliation is a core pharmacist function within a coordinated care team. A systematic review of 17 studies involving 21,342 adults found lower pooled risks of readmission, emergency department visits, and adverse event–related hospital revisits with pharmacist-led programs4; however, programs often included counseling and follow-up, and results varied. A subsequent Cochrane review found uncertain clinical benefits and no clear reduction in unplanned rehospitalizations.5 These findings support careful program design without promising that reconciliation alone will prevent poststroke readmissions.

At the time of admission, pharmacists should build a verified medication history using patient or caregiver interviews, dispensing information, and available records, including nonprescription medications and supplements. Pharmacy records help establish what was dispensed but may not reflect how medications were taken. At each transition, compare the prior regimen with current orders, resolve unintended discrepancies, and document the reason for medications being started, stopped, held, or adjusted.1

For patients who survive stroke, this review must extend beyond drug names and doses. The 2026 American Heart Association/American Stroke Association guideline recommends bedside swallowing screening before liquid or food intake. If screening is failed or cannot be completed because of neurologic disabilities, instrumental assessment with flexible endoscopic evaluation of swallowing or a videofluoroscopic swallow study is reasonable.6 Dysphagia also requires a formulation-specific assessment with the swallowing team. In a 2025 study of 60 patients with acute stroke and dysphagia, routine crushing did not improve swallowing safety and increased residue. The findings do not mean that whole tablets are safe for every patient.7 Pharmacists should check whether tablets can be crushed or capsules opened and select alternatives consistent with the swallowing assessment and product instructions.8

Counseling also needs to match each patient’s abilities. Use plain language and teach-back or a demonstration that involves the caregiver who will manage medications.9 Assess whether the patient can follow the administration instructions and handle the selected formulation.8

Supporting the Rehabilitation Transition to Home

The move to rehabilitation or skilled nursing care introduces another medication handoff. Pharmacists can compare the receiving facility’s orders with the hospital plan and clarify whether differences are intentional. Written explanations of medication changes help the next team distinguish a purposeful adjustment from an error.1

During rehabilitation, review whether the regimen remains appropriate as oral intake, blood pressure, mobility, and supervision change. Practical priorities include reviewing medications when hypotension, hypoglycemia, or sedation occurs, and communicating findings to the treating team. Document the ongoing blood pressure goal and plan for held medications, recognizing that acute stroke management differs from long-term prevention.1,6

Before discharge home, confirm that prescriptions can be obtained. Address insurance, cost, transportation, and pharmacy-access problems, and coordinate unresolved needs with the outpatient team. These navigation activities were components of a pharmacy-based transitional-care program, although that study does not establish their independent benefit in stroke rehabilitation.10

Pharmacist-Led Discharge Counseling and Follow-Up

Discharge counseling should cover the entire regimen, especially antithrombotics. Verify the indication, duration, and subsequent regimen. For example, the 2026 guideline recommends 21 days of aspirin plus clopidogrel, initiated within 24 hours of symptom onset, followed by single antiplatelet therapy for minor noncardioembolic ischemic stroke (National Institutes of Health Stroke Scale score ≤3) without intravenous thrombolysis.6 This regimen is not appropriate for every stroke survivor. When dual therapy is prescribed, specify which agent stops, when it stops, and which continues.

Provide a medication-specific plan addressing administration, missed doses, potential interactions, adverse effects, and who to contact. For antithrombotics, include bleeding precautions and when urgent evaluation is needed. Ask patients or caregivers to explain or demonstrate the plan, then address misunderstandings before discharge.9

Follow-up should verify that medications were obtained, compare actual home use with the discharge plan, and identify unresolved discrepancies or medication-related problems. Assign responsibility for communicating concerns to the prescriber and for keeping the medication list current.1,10

Conclusion

Stroke recovery occurs across multiple care settings, and medication needs change along the way. Pharmacists can help patients and caregivers navigate these changes through reconciliation, individualized counseling, access to support, and follow-up. For patients such as JP, a clear and workable medication plan is an essential part of the transition home.

Pharmacist Checklist: Hospital to Home1,6,8-10

  • Before discharge: Verify the medication history, indications, changes, and unresolved discrepancies.
  • During rehabilitation: Reassess tolerability, administration needs, and the rationale for changes.
  • Before going home: Confirm the antithrombotic plan, medication supply, caregiver responsibilities, and follow-up contact.
  • At counseling: Use teach-back or demonstration and provide an understandable medication list.
  • After discharge: Confirm access and actual use; resolve and communicate medication-related problems.
REFERENCES
1. Chapter 3. Developing change: designing the medication reconciliation process. In: Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation. Agency for Healthcare Research and Quality. Updated July 2022. Accessed September 19, 2026. https://www.ahrq.gov/patient-safety/settings/hospital/match/chapter-3.html
2. Appelros P, Nydevik I, Terént A. Living setting and utilisation of ADL assistance one year after a stroke with special reference to gender differences. Disabil Rehabil. 2006;28(1):43-49. doi:10.1080/09638280500165278
3. Rohde D, Gaynor E, Large M, et al. Cognitive impairment and medication adherence post-stroke: a five-year follow-up of the ASPIRE-S cohort. PLoS One. 2019;14(10):e0223997. doi:10.1371/journal.pone.0223997
4. Mekonnen AB, McLachlan AJ, Brien JA. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6(2):e010003. doi:10.1136/bmjopen-2015-010003
5. Redmond P, Grimes TC, McDonnell R, Boland F, Hughes C, Fahey T. Impact of medication reconciliation for improving transitions of care. Cochrane Database Syst Rev. 2018;8(8):CD010791. doi:10.1002/14651858.CD010791.pub2
6. Prabhakaran S, Gonzalez NR, Zachrison KS, et al; FAHA Peer Review Committee. 2026 guideline for the early management of patients with acute ischemic stroke: a guideline from the American Heart Association/American Stroke Association. Stroke. 2026;57(8):e316-e436. doi:10.1161/STR.0000000000000513. Published correction appears in Stroke. 2026;57(8):e461-e467. doi:10.1161/STR.0000000000000530
7. Trapl-Grundschober M, Struhal W, Teuschl Y, Schulz S, Sollereder S, Osterbrink J. Medication administration in poststroke dysphagia: evaluating swallowing safety of solid dosage forms. Stroke. 2025;56(9):2494-2502. doi:10.1161/STROKEAHA.125.051237
8. Choosing medicines formulations in swallowing difficulties. NHS Specialist Pharmacy Service. Updated February 6, 2025. Accessed September 19, 2026. https://www.sps.nhs.uk/articles/choosing-medicines-formulations-in-swallowing-difficulties/
9. Brach C, ed. AHRQ Health Literacy Universal Precautions Toolkit. 3rd ed. Agency for Healthcare Research and Quality; 2024. AHRQ publication 23-0075; tools 5 and 16. Accessed September 19, 2026. https://www.ahrq.gov/health-literacy/improve/precautions/toolkit.html
10. Ni W, Colayco D, Hashimoto J, et al. Impact of a pharmacy-based transitional care program on hospital readmissions. Am J Manag Care. 2017;23(3):170-176. https://www.ajmc.com/view/impact-of-a-pharmacy-based-transitional-care-program-on-hospital-readmissions

Related to this article